Open | $0.879 |
Close | $1.040 |
Volume / Avg. | 556.914K / 1.953M |
Day Range | 0.850 - 1.169 |
52 Wk Range | 0.245 - 4.038 |
Market Cap | $58.753M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Renalytix (NASDAQ: RNLX) through any online brokerage.
Other companies in Renalytix’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Trxade Health (NASDAQ:MEDS) and Definitive Healthcare (NASDAQ:DH).
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on Friday, June 30, 2023. The analyst firm set a price target for 5.00 expecting RNLX to rise to within 12 months (a possible 410.26% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Renalytix (NASDAQ: RNLX) is $0.9799 last updated March 18, 2024 at 7:33 PM EDT.
There are no upcoming dividends for Renalytix.
Renalytix’s Q3 earnings are confirmed for Friday, June 7, 2024.
There is no upcoming split for Renalytix.
Renalytix is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.